These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7252836)

  • 1. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine].
    Pospelova LN; Chistiakov VV
    Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of allyl isopropyl acetamide on d-aminolevulinic acid synthetase and cytochrome P-450.
    Klinger W; Müller D
    Acta Biol Med Ger; 1980; 39(1):107-112. PubMed ID: 7424328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme.
    Farrell GC; Correia MA
    J Biol Chem; 1980 Nov; 255(21):10128-33. PubMed ID: 7430117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)].
    Richter E; Gallenkamp H; Brachtel D; Grün M
    Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
    Bornheim LM; Underwood MC; Caldera P; Rettie AE; Trager WF; Wrighton SA; Correia MA
    Mol Pharmacol; 1987 Aug; 32(1):299-308. PubMed ID: 3302670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic heme metabolism: new aspects and speculations.
    Schmid R
    Semin Liver Dis; 1983 Feb; 3(1):83-6. PubMed ID: 6340210
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of vinyl chloride: destruction of the heme of highly purified liver Microsomal cytochrome P-450 by a metabolite.
    Guengerich FP; Strickland TW
    Mol Pharmacol; 1977 Nov; 13(6):993-1004. PubMed ID: 413029
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of rat liver cytochrome P-450 by benzyl hydrodisulfide.
    Sawahata T; Neal RA
    Mol Pharmacol; 1982 Mar; 21(2):464-7. PubMed ID: 6896554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the in vitro metabolism of allylisopropylacetamide to reactive intermediates. Mechanistic studies with oxygen-18.
    Prickett KS; Baillie TA
    Biomed Mass Spectrom; 1984 Jul; 11(7):320-31. PubMed ID: 6478043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon inducing agents (polyriboinosinic acid. Polyribocytidylic acid, tilorone) on hepatic hemoproteins (cytochrome P-450, catalase, tryptophan 2,3-dioxygenase, mitochondrial cytochromes), heme metabolism and cytochrome P-450-linked monooxygenase systems.
    el-Azhary R; Mannering GJ
    Mol Pharmacol; 1979 May; 15(3):698-707. PubMed ID: 492152
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of phenobarbital on the impairment of drug metabolism by carrageenan-induced inflammation in male rat.
    Sasaki K; Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):377-80. PubMed ID: 2236905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hepatic microsomal cytochrome P-450 hemeproteins in diabetic rats.
    Past MR; Cook DE
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):329-37. PubMed ID: 6768119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ; Bachmann KA; Andres FF; Flynn MG; Sherman GP; Rodriguez-Zayas J
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional reconstitution of rat liver cytochrome P-450 with mesohemin.
    Bornheim LM; Correia MA; Smith KM
    Biochem Biophys Res Commun; 1984 May; 121(1):95-101. PubMed ID: 6732820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated conversion of heme to bile pigments caused in the liver by carbon disulfide and other sulfur-containing chemicals.
    Järvisalo J; Gibbs AH; de Matteis F
    Mol Pharmacol; 1978 Nov; 14(6):1099-106. PubMed ID: 732810
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
    Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.